Lisa is the Chief Innovation Officer for the Henry Ford Health System. She has successfully created and driven the institution’s agenda for leveraging technology, intellectual property, and clinical expertise – all designed to improve patient care, create value for the institution and its partners, and foster economic development. She led the System’s successful entry into international markets by developing a resilient business model, identifying high performing partners, and managing rigorous analyses of business and legal issues such as foreign corrupt practices. Projects in the Middle East and India have created a future revenue pipeline of over $250 million. She also leads the Global Technology Program for U.S. health systems to partner with early stage companies in the U.S., Israel and India.

Lisa has been a serial entrepreneur and strategic advisor to universities and hospitals. Additionally, she raised and served as General Partner (GP) for an investment fund which was successfully deployed to create real estate development around universities. Earlier she rose the ranks of the University of Pennsylvania transitioning from business development, innovation, and executive positions. She began her career at the public accounting firm of Coopers & Lybrand.

Lisa is a collaborator, mentor and inspired business partner committed to the highest ethics as a cornerstone of corporate resiliency. She holds Masters degrees in Government Administration (MGA) and International Relations (MA) from the University of Pennsylvania, and Bachelor’s degree from University of Michigan.

Joe has over 23 years of experience in healthcare, covering technology deployment, management consulting, founding two successful businesses in the sector and subsequently five years of investing. He joined Octopus Ventures as Partner in January 2021, with the intention to launch a new £100 million institutional global fund to invest in early-stage healthtech businesses. With a lifelong passion for healthcare and technology, Joe previously launched TenX Health on the back of leading Google Health in the UK and the Ventures and Healthcare practices for EY in the UK. At EY, he was the global healthcare supply chain leader, ran a UK team of 120 healthcare specialists and founded and jointly led three technology businesses in the UK NHS. Joe has led some of the most significant and high profile transformation programmes in UK healthcare – for example a four year / £14bn programme to transform the NHS supply chain. Joe is a Board Trustee of the Royal Society of Public Health.

Dan Lasserson is Professor of Acute Ambulatory Care at the University of Warwick, working clinically in the Acute Hospital at Home services for Oxford University Hospitals NHS Foundation Trust and Sandwell and West Birmingham NHS Trust. He is a founder member of the UK Hospital at Home Society. He has previously worked in primary care as well as his current role in hospital medicine and is the Theme Lead for Acute Care Interfaces in the NIHR Applied Research Collaboration (ARC) West Midlands. He is also Theme lead for Acute Ambulatory Care in the NIHR Community Healthcare MedTech and In-Vitro Diagnostic Cooperative (MIC). He is the chief investigator of an NIHR Policy Research Programme study examining the optimal acute medical care delivery model during winter and waves of COVID-19. He leads the NIHR STOPAPE trial on the management of sub-segmental pulmonary embolism and also works on the NIHR CONDOR study, examining point of care tests for COVID-19 and AVID-CC, a Wellcome Trust Therapeutics Accelerator funded trial examining how a TNF antibody could improve outcomes for patients in care homes with COVID-19. His work for the Society for Acute Medicine includes leading its national hospital benchmarking audit (SAMBA), sitting on the Society for Acute Medicine’s Research Committee and being a member of the Editorial Board of the Acute Medicine Journal.

Dr Ronald Whelan is Chief Commercial Officer of Discovery Health. A medical doctor by training with an MBA, he was Associate Partner at McKinsey from 2006 to 2013 during which time he co-led  McKinsey’s healthcare practice across sub-Saharan Africa.

From 2013 to 2019 he was Partner and Head of Healthcare Investments at Spinnaker Growth Partners where he led investments and business development across a range of healthcare ventures and was founder of Healthforce, a leading telemedicine player in South Africa.

Dr Whelan has extensive experience in clinical and corporate  healthcare spanning more than 20 years and 25 countries globally.

Education, professional career

1979 Medical examination, University of Cologne

2/1980 Doctoral degree (Dr. med., summa cum laude)  

1980 Postdoctoral Fellow, University of Cologne

1985 Research Assistant (C1), Dept. of Physiology, FU

7/1990 Habilitation, Medical Faculty, Freie Universität Berlin (FU)

1991 Lecturer of Physiology (C2), Dept. of Physiology, FU

1995 Associate Professor, Dept. of Physiology, FU

1997‐1998 Senior Physician, Anaesthesiology, German Heart Centre Berlin (DHZB)

12/1998 Full Professor, Dept. of Physiology, FU

1984‐2014 University of Arizona, Tucson, Consultant for NIH grants with Tim Secomb, (yearly stays of one month at UofA).

2001‐2015 Head, Institute of Physiology, Charité ‐ Universitätsmedizin Berlin

2003‐2015 Board Member, Faculty of Medicine, Charité ‐ Universitätsmedizin Berlin

2008‐2015 Vice Director, Centre for Preclinical Medicine, Charité

2009‐2013 Vice Director, Centre for Cardiovascular Research, CCR, Charité

2015‐present Dean, Charité ‐ Universitätsmedizin Berlin

2018‐present CEO (interim) Berlin Institute of Health (BIH)  

Honours, Awards, Fellowships

1980 Thesis Award “Hochhausstiftung”, University of Cologne

1986 Abbott Microcirculation Award, European Society for Microcirculation

1995 Lafon Hemorheology‐Microcirculation Award, International Society for Clinical Haemorheology  

2000 Fellow, European Society of Cardiology

2008 Visiting Fellowship, Isaac Newton Institute for Mathematical Sciences, Cambridge/UK

2008 Award of the Asian Union for Microcirculation

2011 Malpighi Award, European Society for Microcirculation

2015 William Harvey Basic Science Lecture and Silver Medal, European Society of Cardiology (ESC)

2015 Kitanomaru Award, 10th World Conf. for Microcirculation, Kyoto, Japan

2018 Poiseuille Gold Medal, International Society of Biorheology

Professional Activities

Editorial boards - Cardiovascular Research (associate editor 2012‐2018); Journal of Vascular Research; Microcirculation; Pflügers Archive European Journal of Physiology; Biorheology; PLoS Computational Biology; The Keio Journal of Medicine, Journal of Cardiovascular Medicine; Frontiers in Vascular Physiology, Frontiers in Computational Physiology and Medicine; Bulletin of the Portuguese Society of Hemorheology and Microcirculation.

Leading Functions in Scientific Societies

European Society of Cardiology (ESC)

Congress Programme Committee - Basic Science Coordinator 2005‐2010; 2012‐2014

Council on Basic Cardiovascular Science (CBCS) - Nucleus 2004‐present

Chair - 2010‐2012

Frontiers of Cardiovascular Biology (FCVB), Chairperson 2010

Working Group on Coronary Pathophysiology and Microcirculation - Nucleus 1994‐2002; 2007‐2012; 2014‐2018

Chair - 1998‐2000

CardioScape - Scientific Committee 2012‐2014

Chair - 2015‐present

European affairs committee - 2014‐2016

Advocacy committee - 2016‐present

Alliance for Biomedical Research in Europe - 2016‐present

Member of the Board of Directors - 2017

President - 2018‐2019

International Union of Physiological Societies (IUPS)

Commission on Microcirculation and Capillary Transport Physiome and Bioengineering Committee - 2004‐2010

European Society for Microcirculation (ESM) Strategy committee - 1995‐1998; 2011‐2015

General Secretary - 1998‐2011

International Liaison Committee for Microcirculation (ILCM) Member - 200‐2006; 2015‐present

Chair - 2006‐2015

German Society for Microcirculation and Vascular Biology Board - 1990‐1994; 2011‐2015

General Secretary - 1996‐2011

Organization

Conferences (president, co‐president and organization) 6

Symposia (organizer) 46

Member of international scientific program committee 38

Major Research fields

Blood rheology, Microcirculation, Organ perfusion, Endothelial function, Endothelial surface, Vascular adaptation, Angiogenesis, Tumour microcirculation

Cooperations (selected)

Mark Dewhirst, Duke University, Durham, USA; David Boas, Havard University, Cambridge, USA;   Klaus Ley, LIAI, San Diego, USA; Tim Secomb, University of Arizona, Tucson, USA; Saul Yedgar, Hebrew University, Jerusalem, Israel; Valentin Djonov, University of Bern, Switzerland; Ferdi le Noble: KIT Karlsruhe, Germany.

Selected Major Publications (H‐Index: 52, Citations > 10000)

CardioScape mapping the cardiovascular funding landscape in Europe.Pries AR, et al. European Heart Journal 2018; 39(25):2423‐2430.

Coronary microcirculatory pathophysiology: can we afford it to remain a black box? Pries AR and Reglin B. European Heart Journal 2017 Feb 14;38(7):478‐488.

Coronary vascular regulation, remodelling, and collateralization: mechanisms and clinical implications on behalf of the working group on coronary pathophysiology and microcirculation. Pries AR, et al. European Heart Journal 2015; 36(45): 3134‐3146.

Making microvascular networks work: angiogenesis, remodeling, and pruning. Pries AR and Secomb TW. Physiology (Bethesda) 2014; 29(6): 446‐455.

Precapillary oxygenation contributes relevantly to gas exchange in the intact lung. Tabuchi A, Styp‐Rekowska B, Slutsky AS, Wagner PD, Pries AR*, Kuebler WM* (*these authors share senior authorship). Am J Respir Crit Care Med 2013; 188(4): 474‐481.

Pulsatile shear and Gja5 modulate arterial identity and remodeling events during flow‐driven arteriogenesis. Buschmann I*, Pries A*, Styp‐Rekowska B et al (*these authors contributed equally). Development 2010; 137(13): 2187‐2196.

The shunt problem: control of functional shunting in normal and tumour vasculature. Pries AR, Hopfner M, Le Noble F, Dewhirst MW, Secomb TW. Nature Rev Cancer 2010; 10(8): 587‐593.

Remodeling of blood vessels: responses of diameter and wall thickness to hemodynamic and metabolic stimuli. Pries AR, Reglin B, Secomb TW. Hypertension 2005; 46(4): 726‐731.

The endothelial surface layer. Pries AR, Secomb TW, Gaehtgens P. Pflugers Arch 2000; 440(5): 653‐666.

Design principles of vascular beds. Pries AR, Secomb TW, Gaehtgens P. Circ Res 1995; 77(5): 1017‐1023.

Resistance to blood flow in microvessels in vivo. Pries AR, Secomb TW, Gessner T, Sperandio MB, Gross JF, Gaehtgens P. Circ Res 1994; 75(5): 904‐915.

Blood viscosity in tube flow: dependence on diameter and hematocrit. Pries AR, Neuhaus D and Gaehtgens P. Am J Physiol 263: H1770‐H1778, 1992. Blood flow in microvascular networks ‐ experiments and simulation. Pries AR, Secomb TW, Gaehtgens P and Gross JF. Circ Res 67: 826‐834, 1990.

Red cell distribution at microvascular bifurcations. Pries AR, Ley K, Claassen M and Gaehtgens P. Microvasc Res 38: 81‐101, 1989.

Aviv Shoher is the CEO of Ichilov Tech, the innovation company of the Tel-Aviv Sourasky Medical Center.

He served as CEO and founder of five startup companies in Israel and in the US and, in addition to scouting out new technologies on behalf of RAD and UIC’s Office of Technology Management, he served as Director of Business Development at Captek and as Senior Vice-President of Business Development at Yissum – Hebrew University. 

Aviv earned his MBA with a focus on Health Enterprise Management from Northwestern University’s Kellogg School of Management. In addition, he holds a Law degree, magna cum laude, and a BA in Economics from Tel Aviv University. He is a member of 8400 – The Health Network and of the FHIR-IL leadership team.

Dr. Yaniv has more than 25 years of experience in the venture capital, pharmaceutical and biotech industries. As a senior manager, skilled physician, and experienced board member, she possesses a highly developed combination of leadership, decision making and business skills.  Dr. Yaniv has served as partner at Accelmed since 2012.  During this time, she led Eximo from pre-clinical development through acquisition.

Dr. Irit Yaniv previously served as Executive Director and Chairperson of Accelmed's Innovation Hub portfolio companies. A global group of funds investing and acquiring control in HealthTech companies focused on Buyout and Non-Control transactions in commercial stage companies.

Dr. Yaniv holds an MD degree from the Ben-Gurion University and an MBA from the Recanati Business School at Tel Aviv University.

Internal Medicine specialist. President of the Spanish Society of Hospital at Home. Head of the Home Hospitalization Service, Torrejón University Hospital. Coordinator of the Hospitalization and Telemedicine Working Group of the Spanish Society of Internal Medicine. Coordinator of the Spanish Home Intravenous Antimicrobial Therapy Registry. Member of the Steering Group of the national strategic plan for Home Hospitalization 2020. Master in Management of Clinical Units. University Expert in Health Management. Author of books and national and international publications. Speaker and moderator in forums and scientific events. Tutor at the Francisco de Vitoria University. Director of several postgraduate training activities.

Amir is the Chief Digital Officer for Healthcare Israel and leads strategic digital health cooperation with countries and international bodies around the world. He manages collaboration projects and Government-to-Government (G2G) joint relationships to bring Israel’s E-health solutions and innovations to the world. Key projects include the National Health Information Exchange infrastructure (HIE), open-source EMR application for small clinics, national health-oriented Big-Data research platform, national B2B\B2C Telemedicine platform, and more. Amir has 15 years of experience in IT projects, including 5 years as Program Manager for two national IT healthcare programs for Israel’s Ministry of Health (National Emergency Room Program and Electronic Health Records), as well as 3 years managing complex computing projects in the field of national systems.

Avner Halperin is an entrepreneur and executive in the fields of Digital Health and Big Data Analytics. He is Chairman of the Board at EyeControl – winner of the Genesis Award for significant contribution to helping battle COVID-19.  In addition, he leads Global ARC and City of Health Innovation for Sheba Medical Center – ranked as one of the Top 10 Best Hospitals in the world.  Previously, he was CEO of EarlySense for 15 years - bringing the company from the idea stage to over 1,000,000 patients served.  Prior to that, Avner was CEO of Emmunet, VP Marketing at Radcom (NASDAQ: RDCM), and R&D team leader at Eldat Communications (acquired by Pricer(PRIC.ST)).  Earlier, he was Department Head of an R&D Unit in the Israeli Defence Forces Intelligence Corps where he won the Intelligence Innovation Award.

Avner earned an M.Sc. in Applied Physics from Tel Aviv University and an MBA from the MIT Sloan Fellows Executive MBA Program.  He has been teaching courses on Economics and Entrepreneurship in the Hebrew University of Jerusalem and Tel Aviv University.  His research papers and 33 US Patents have been cited over 3,700 times. 

Ori is an executive and entrepreneur with over 25 years of experience in the IT, Internet, telecommunications, medical device and digital health. Prior to Medial EarlySign, he was involved in diverse projects related to data modeling, knowledge representation, search and analytics in multiple development, ideation and management roles. He worked with the Department of Defense, software innovation in a medical devices company, was co-founder and CEO in an internet community venture, a co-founder of financial services company, and held VP roles at Pontis, a company involved in Big Data real-time personalized marketing for large network operators (acquired by Amdocs symbol:DOX). Ori is involved in digital health, machine learning and predictive modeling since 2009. Ori holds BS in mathematics and computer science, cum laude, from Bar-Ilan University.

Mr. Vikram Thaploo, CEO – TeleHealth at Apollo Hospitals Enterprise Limited.

With above two decades of experience in diverse industries including healthcare, retail and hospitality, Vikram Thaploo is a veteran of strategizing innovative projects and creating sustainable business models.

Vikram is currently leading Remote Healthcare Practice and Public Private Partnerships at Apollo Hospitals. This comprises of Apollo TeleHealth (Healthcare delivery and TeleClinics Company), HealthNet Global Limited (Healthcare Technology Company) and Apollo Telemedicine Networking Foundation (Not-for-profit Company) along with the government business vertical.

A management professional from Indian School of Business with extensive experience in setting up and scaling up businesses, Vikram has a superior track record in conceptualizing ideas and implementing them for successful business expansion. He is one of the Global names in the field of Telemedicine. His mission is to make healthcare accessible to all using the convergence of Technology, Telecom, and MedTech ecosystems, thus, delivering Continuum of Care. Over the years he has been aggressively working towards elevating Public Health care delivery and Rural Healthcare.

Sumit Singh is a dedicated Technology Executive leader with over 29 years of experience specialising in Healthcare and Finance verticals within the United States, India and UAE. He has a proven record of accomplishment delivering business transformation through strategic and tactical technology initiatives. He has been with VPS Healthcare since spring 2019 as its technology leader, spearheading the technology transformation for the group across various healthcare businesses of VPS globally. Prior to VPS Healthcare, Sumit was Vice President and CIO with Wockhardt Hospitals Limited based out of Mumbai, India for 8 years. Earlier, he was based out of US for 20 years, and after completing his education, started his career there gaining deep understanding of the US financial markets while having worked with various organizations such as Ernst & Young LLP, TD Ameritrade Holding Corp. (now Charles Schwab), OnMoney Inc., Prodigy Services Company (IBM Company) and Clemson University. He has extensive experience in deployment of enterprise wide IT application, infrastructure and of business continuity plans along with continued maintenance and upgrade responsibilities. Over the years, he has been part of some key M&As.

His areas of expertise are:

• IT Governance and Execution of large complex IT projects
• Deliver customer value, executing strategic plans, while promoting growth and expansion
• Full Life-Cycle project management: Conceptualization to Delivery
• People Leadership – Building, Managing, Mentoring and Coaching
• Vendor/Partner evaluations and management for outsourced projects
• Budget Management — Documentation — IT-Related Purchasing

He has done his MS in Computer Communications from Clemson University followed by an MBA in Finance from Pace University, both in USA. He also holds a Bachelor’s Degree in Electronics Engineering from Bangalore University. Apart from this, he has attended various leadership programs, received numerous recognitions, and has many certifications in areas of Management and IT.

Besides work, Sumit takes interest in music, light writing, current affairs and leisure travel.

Aditi U. Joshi MD, MSc is a Senior Advisor in Telehealth and Assistant Professor of Emergency Medicine at Thomas Jefferson University Hospital. Her position at TJUH is multi-faceted in telehealth and tele-intake: working in operations, quality assurance, provider training, resident and medical education and implementing new programs and use cases for telehealth. She is director of a Telehealth fellowship aimed at training future physicians interested in leading virtual care. Nationally, she serves as the Chair for the Telehealth committee of the American College of Emergency Physicians, helping expand the role of telehealth within the specialty.

Aviad Tamir is the Head of Life Sciences & Healthcare at Invest in Israel, helping multinationals and investors to establish their operations in Israel. His professional experience spans across Israel and abroad working with Pharmaceutical & Healthcare industries, specializing in International Business Development & Strategic Partnerships within the private and public sectors. Previously, Aviad worked at the Ministry of Defense, Mission to the U.S. managing procurement projects for the IDF, and the Office of the Prime Minister as an Advisor to the Director General of the Ministry for Senior Citizens.